Status:
COMPLETED
Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects
Lead Sponsor:
PharmaEssentia
Collaborating Sponsors:
PharmaEssentia Japan K.K.
Conditions:
Healthy Volunteer
Eligibility:
MALE
20-65 years
Phase:
PHASE1
Brief Summary
Skin Irritation and Phototoxicity Study of KX01 Ointment 1% in Japanese healthy male subjects
Detailed Description
A baseline evaluation of the patch sites will be performed immediately prior to application of the patches to ensure that no conditions, markings, or coloration of the skin will interfere with interpr...
Eligibility Criteria
Inclusion
- Healthy Japanese male adult, whose age 20-65 years old
Exclusion
- History of photosensitivity or photoallergy
Key Trial Info
Start Date :
November 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05245578
Start Date
November 16 2021
End Date
January 12 2022
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Corporation HOUEIKAI, Sekino Clinical Pharmacology Clinic
Toshima-ku, Tokyo, Japan, 171-0014